| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3992461 | Journal of Thoracic Oncology | 2007 | 5 Pages |
Abstract
There was no significant survival difference between NSCLC patients with PM1 and PM2. The survival of patients with PM1 was between that of the T3 and T4 patients excluding PM1.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Kanji MD, Yasunori MD, Ryosuke MD, Tomoyuki MD, Etsuo PhD, for The Japan Lung Cancer Registration Committee for The Japan Lung Cancer Registration Committee,